Geneva, June 4 -- International Clinical Trials Registry received information related to the study (CTIS2024-519327-20-00) titled 'A study to test how well multiple doses of BI 3810477 are tolerated by healthy adults' on March 3.
Study Type: Interventional clinical trial of medicinal product
Study Design:
Controlled: no Randomised: no Open: no Single blind: no Double blind: no Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: no Number of treatment arms in the trial:
Primary Sponsor: Boehringer Ingelheim International GmbH
Condition:
Healthy volunteer trial
Therapeutic area: Not possible to specify
Recruitment Status: Recruiting
Phase: Human pharmacology (Phase I)...